About 4P Pharma
4P Pharma is a company based in Lille (France) founded in 2014. 4P Pharma has raised $18.49 million across 2 funding rounds from investors including Bpifrance and Satt Lutech. 4P Pharma offers products and services including 4P004 and 4P025. 4P Pharma operates in a competitive market with competitors including Indivior, Biotie, Ethypharm, Braeburn and Opiant Pharmaceuticals, among others.
- Headquarter Lille, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.49 M (USD)
in 2 rounds
-
Latest Funding Round
$16.04 M (USD), Series B
Apr 29, 2024
-
Investors
Bpifrance
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of 4P Pharma
4P Pharma offers a comprehensive portfolio of products and services, including 4P004 and 4P025.
GLP-1 analog for treating osteoarthritis and reducing inflammation.
AI-derived treatment for primary sclerosing cholangitis liver condition.
People of 4P Pharma
Unlock access to complete
Funding Insights of 4P Pharma
4P Pharma has successfully raised a total of $18.49M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $16.04 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in 4P Pharma
4P Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Bpifrance and Satt Lutech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Facilitates maturation of inventions into commercial innovations for businesses and researchers.
|
Locked | Locked | Locked | |
|
Corporate consultancy, advisory, and funding services are provided to businesses.
|
Locked | Locked | Locked |
Investor details for 4P Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 4P Pharma
Investment portfolio details for 4P Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 4P Pharma
Detailed financials for 4P Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
4P Pharma Comparisons
Peer comparison for 4P Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 4P Pharma
4P Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indivior, Biotie, Ethypharm, Braeburn and Opiant Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for opioid addiction treatment are developed and commercialized.
|
|
| Locked | Locked | Locked |
Drugs for neurodegenerative and psychiatric disorders are developed by Biotie.
|
|
| Locked | Locked | Locked |
Therapies for pain and addiction treatment are developed.
|
|
| Locked | Locked | Locked |
Long-acting therapies for opioid addiction and chronic pain are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for addictive and eating disorders are developed.
|
|
| Locked | Locked | Locked |
Therapies for substance use disorders are developed by Amygdala Neurosciences.
|
Detailed competitors of 4P Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 4P Pharma
Complete news archive for 4P Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 4P Pharma
4P Pharma was founded in 2014 and raised its 1st funding round 7 years after it was founded.
4P Pharma is headquartered in Lille, France. It is registered at Lille, Hauts-de-france, France.
4P Pharma is a funded company, having raised a total of $18.49M across 2 funding rounds to date.
4P Pharma was established in 2014 in Lille, France, as a preclinical biotech startup. Drug candidates are in-licensed from university research and small biotechs, then advanced to Phase IIIa trials before out-licensing. Operations target cancer, inflammatory diseases, and addiction treatments through New Chemical Entities, biologics, repositioned generics, and fixed-dose combinations. No molecules have entered clinical stages yet.
4P Pharma's top competitors include Indivior, Ethypharm and Amygdala Neurosciences.
4P Pharma offers 4P004 and 4P025.
4P Pharma has 2 investors. Key investors include Bpifrance, and Satt Lutech.